Literature DB >> 7387484

Noninvasive regional cerebral blood flow measurements in dementia.

F Yamaguchi, J S Meyer, M Yamamoto, F Sakai, T Shaw.   

Abstract

Regional cerebral blood flow measured in patients with dementias (N = 60) using xenon Xe 133 inhalation was compared with measurements in health volunteers (N = 70). Volunteers were age-matched (N = 15); another group was younger. In normal aging, there is progressive, diffuse reduction of weight and flow of gray matter (F1) but not of white matter. Therefore, age-matched control subjects are necessary in studies of dementia. In Alzheimer's disease (AD), F1 shows bilateral and symmetrical reduction. The F1 reduction correlated with atrophy estimated by computerized tomography, and duration and severity of dementia. In multi-infarct dementia (MID), bilateral hemispheric F1 was patchily reduced. Cerebral vasodilator response to 5 percent carbon dioxide inhalation was reduced in patients with MID but was normal in patients with AD. Patients with Wernicke-Korsakoff's dementia showed normal values. Patients with dementia due to multiple sclerosis showed significant F1 reduction compared with normal subjects. Standard behavioral activation in all patients with moderate to severe dementia failed to produce normal F1 increases.

Entities:  

Mesh:

Year:  1980        PMID: 7387484     DOI: 10.1001/archneur.1980.00500560040003

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

Review 1.  Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.

Authors:  P L McGeer; H Kamo; R Harrop; D K Li; H Tuokko; E G McGeer; M J Adam; W Ammann; B L Beattie; D B Calne
Journal:  CMAJ       Date:  1986-03-15       Impact factor: 8.262

2.  Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance.

Authors:  Sandeepa Sur; Zixuan Lin; Yang Li; Sevil Yasar; Paul Rosenberg; Abhay Moghekar; Xirui Hou; Rita Kalyani; Kaisha Hazel; George Pottanat; Cuimei Xu; Peter van Zijl; Jay Pillai; Peiying Liu; Marilyn Albert; Hanzhang Lu
Journal:  Neurology       Date:  2020-07-13       Impact factor: 9.910

Review 3.  Beta-amyloid, blood vessels, and brain function.

Authors:  Eric E Smith; Steven M Greenberg
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

Review 4.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Focal cerebral hypoperfusion and selective cognitive deficit in dementia of the Alzheimer type.

Authors:  P Celsis; A Agniel; M Puel; A Rascol; J P Marc-Vergnes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

Review 6.  Cerebral amyloid angiopathy impact on endothelium.

Authors:  Lea Tenenholz Grinberg; Amos D Korczyn; Helmut Heinsen
Journal:  Exp Gerontol       Date:  2012-08-28       Impact factor: 4.032

7.  Cerebral perfusion patterns in vascular dementia of Binswanger type compared with senile dementia of Alzheimer type: a SPECT study.

Authors:  H Tohgi; K Chiba; K Sasaki; S Hiroi; Y Ishibashi
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

8.  Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.

Authors:  Aaron R Switzer; Ikreet Cheema; Cheryl R McCreary; Angela Zwiers; Anna Charlton; Ana Alvarez-Veronesi; Ramnik Sekhon; Charlotte Zerna; Randall B Stafford; Richard Frayne; Bradley G Goodyear; Eric E Smith
Journal:  Neurology       Date:  2020-07-08       Impact factor: 9.910

Review 9.  Neurosonological Examination: A Non-Invasive Approach for the Detection of Cerebrovascular Impairment in AD.

Authors:  Barbora Urbanova; Ales Tomek; Robert Mikulik; Hana Magerova; Daniel Horinek; Jakub Hort
Journal:  Front Behav Neurosci       Date:  2014-01-21       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.